Croma is a Greek startup founded in 2005 with the mission to facilitate market access for pharmaceutical products. Founded by Venia Allamani and Athina Moissidou, who have extensive experience in Regulatory Affairs and Market Access from their leadership roles in multinational pharmaceutical companies, including AstraZeneca, Bayer, and Sandoz. Croma aims to provide strategic support to drive products effectively into the Greek market, emphasizing the significance of Regulatory Affairs in the ever-evolving health sector. Understanding the criticality of Market Access, Croma offers personalized services to assist in navigating the complex approval procedures for product launches in Greece. Despite limited investment information, Croma's focus on the pharmaceutical and marketing industries, along with its Greek headquarters, positions it as a promising player in the healthcare market. With its dedication to overcoming market access barriers, Croma presents an intriguing opportunity for potential investors seeking exposure to the pharmaceutical sector in Greece.
There is no investment information
No recent news or press coverage available for Croma.